Literature DB >> 25064661

Magnitude of influenza virus replication and cell damage is associated with interleukin-6 production in primary cultures of human tracheal epithelium.

Mutsuo Yamaya1, Lusamba K Nadine2, Chiharu Ota2, Hiroshi Kubo2, Tomonori Makiguchi3, Ryoichi Nagatomi4, Hidekazu Nishimura5.   

Abstract

Primary cultures of human tracheal epithelium were infected with influenza viruses to examine the relationships between the magnitude of viral replication and infection-induced cell damage and cytokine production in airway epithelial cells. Infection with four strains of the type A influenza virus increased the detached cell number and lactate dehydrogenase (LDH) levels in the supernatants. The detached cell number and LDH levels were related to the viral titers and interleukin (IL)-6 levels and the nuclear factor kappa B (NF-κB) p65 activation. Treatment of the cells with an anti-IL-6 receptor antibody and an NF-κB inhibitor, caffeic acid phenethyl ester, reduced the detached cell number, viral titers and the LDH levels and improved cell viability after infection with the pandemic influenza virus [A/Sendai-H/N0633/2009 (H1N1) pdm09]. A caspase-3 inhibitor, benzyloxycarbonyl-DEVD-fluoromethyl ketone, reduced the detached cell number and viral titers. Influenza viral infection-induced cell damage may be partly related to the magnitude of viral replication, NF-κB-p65-mediated IL-6 production and caspase-3 activation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airway epithelial cells; Cell damage; Influenza virus; Interleukin-6; Pathogenicity

Mesh:

Substances:

Year:  2014        PMID: 25064661     DOI: 10.1016/j.resp.2014.07.010

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  9 in total

Review 1.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

2.  The non-antibiotic macrolide EM900 inhibits rhinovirus infection and cytokine production in human airway epithelial cells.

Authors:  Nadine Lusamba Kalonji; Kazuhiro Nomura; Tetsuaki Kawase; Chiharu Ota; Hiroshi Kubo; Takeya Sato; Teruyuki Yanagisawa; Toshiaki Sunazuka; Satoshi Ōmura; Mutsuo Yamaya
Journal:  Physiol Rep       Date:  2015-10

3.  Avian leukosis virus subgroup J induces VEGF expression via NF-κB/PI3K-dependent IL-6 production.

Authors:  Yanni Gao; Yao Zhang; Yongxiu Yao; Xiaolu Guan; Yongzhen Liu; Xiaole Qi; Yongqiang Wang; Changjun Liu; Yanping Zhang; Honglei Gao; Venugopal Nair; Xiaomei Wang; Yulong Gao
Journal:  Oncotarget       Date:  2016-12-06

Review 4.  Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy.

Authors:  Elizabeth Q Littauer; Ioanna Skountzou
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

5.  Effects of high temperature on pandemic and seasonal human influenza viral replication and infection-induced damage in primary human tracheal epithelial cell cultures.

Authors:  Mutsuo Yamaya; Hidekazu Nishimura; Nadine Lusamba Kalonji; Xue Deng; Haruki Momma; Yoshitaka Shimotai; Ryoichi Nagatomi
Journal:  Heliyon       Date:  2019-02-05

6.  The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.

Authors:  Mutsuo Yamaya; Yoshitaka Shimotai; Yukimasa Hatachi; Nadine Lusamba Kalonji; Yukiko Tando; Yasuo Kitajima; Kaori Matsuo; Hiroshi Kubo; Ryoichi Nagatomi; Seiji Hongo; Morio Homma; Hidekazu Nishimura
Journal:  Pulm Pharmacol Ther       Date:  2015-07-10       Impact factor: 3.410

Review 7.  Antiviral properties of caffeic acid phenethyl ester and its potential application.

Authors:  Hacı Kemal Erdemli; Sumeyya Akyol; Ferah Armutcu; Omer Akyol
Journal:  J Intercult Ethnopharmacol       Date:  2015-11-05

8.  Optimization of cell-laden bioinks for 3D bioprinting and efficient infection with influenza A virus.

Authors:  Johanna Berg; Thomas Hiller; Maya S Kissner; Taimoor H Qazi; Georg N Duda; Andreas C Hocke; Stefan Hippenstiel; Laura Elomaa; Marie Weinhart; Christoph Fahrenson; Jens Kurreck
Journal:  Sci Rep       Date:  2018-09-17       Impact factor: 4.379

9.  The clinically used serine protease inhibitor nafamostat reduces influenza virus replication and cytokine production in human airway epithelial cells and viral replication in mice.

Authors:  Mutsuo Yamaya; Yoshitaka Shimotai; Ayako Ohkawara; Enkhbold Bazarragchaa; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida; Hidekazu Nishimura
Journal:  J Med Virol       Date:  2020-12-17       Impact factor: 20.693

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.